medigraphic.com
Instituto Nacional de Salud Pública

2003, Number 2

<< Back Next >>

salud publica mex 2003; 45 (2)

Epidemiology of Tuberculosis in Mexico, 1981-1998 Inconsistencies between reports from the World Health Organization and the Ministry of Health

Báez-Saldaña AR, Pérez-Padilla JR, Salazar-Lezama MÁ

Language: Spanish
References: 25
Page: 78-83
PDF size: 92.28 Kb.


ABSTRACT

Objective. To describe the tuberculosis morbidity and mortality trends in Mexico, by comparing the data reported by the Ministry of Health (MH) and the World Health Organization (WHO) between 1981 and 1998. Material and Methods. The number of cases notified in the past few years, their rates, and the trends of the disease in Mexico were analyzed. The incidence of smear-positive pulmonary tuberculosis was estimated for 1997 and 1998 with the annual tuberculosis infection risk (ATIR), to estimate the percentage of bacilliferous cases in 1997-1998. Results. WHO reported more tuberculosis cases for Mexico than the MH. However, this difference has decreased throughout the years. The notification of smear-positive cases remained stable during 1993-1998. The estimated percentages of detection were 66% for 1997 and 26% for 1998 (based on ATIR of 0.5%). Tuberculosis mortality decreased gradually (6.7% per year) between 1990 and 1998, whereas the number of new cases increased, suggesting the persistence of disease transmission in the population. Conclusions. Inconsistencies between case notifications from national data and WHO were considerable, but decreased progressively during the study period. According to ATIR estimations, a considerable number of infectious tuberculosis cases are not detected.


REFERENCES

  1. Enarson DA. Commentary. Why not the elimination of tuberculosis. Mayo Clin Proc 1994; 69:85-86.

  2. World Health Organization. Global tuberculosis control, communicable diseases. Ginebra: 1999.

  3. World Health Organization. What is DOTS?: A guide to understanding the WHO-recommended TB control strategy known as DOTS. Ginebra: WHO, 1999.

  4. Grzybowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc Lung Dis 1975; 50:90-106.

  5. Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954; 69:724-732.

  6. Rieder HL. Bases epidemiológicas del control de la tuberculosis. París: Unión Internacional contra la Tuberculosis y Enfermedades Respiratorias. 1999.

  7. Friedman LN. Tuberculosis. Current concepts and treatment. New Haven (CT): 1994:286-301.

  8. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161:1376-1395.

  9. Organización Panamericana de la Salud. Informe. El control de la Tuberculosis en las Américas. Washington, D.C.: OPS, 2000.

  10. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis, morbidity and mortality of a worldwide epidemic. JAMA 1995; 273:220-226.

  11. Styblo K. Relación entre riesgo de infección tuberculosa y riesgo de desarrollar una tuberculosis contagiosa. Bol Union Int Tuberc Enf Resp 1985; 60:117-119.

  12. Caminero LJA. Medidas básicas para el control de la tuberculosis en una comunidad. Med Clin 1994; 102:67-73.

  13. Grzybowski S. A propósito de la historia natural de la tuberculosis. Bol Union Int Tuberc Enf Resp 1991; 66:213-214.

  14. World Health Organization. Tuberculosis Control in Mexico: Joint Programme Review. Ginebra: WHO, junio 1995.

  15. García-García ML, Small PM, García-Sancho C, Mayar-Maya ME, Ferreyra- Reyes L, Palacios-Martínez M et al. Tuberculosis epidemiology and control in Veracruz, Mexico. Int J Epidemiol 1999; 28:135-140.

  16. Caminero LJA. Editorial. Situación actual de la tuberculosis en España Arch Bronconeumol 1994; 30:371-374.

  17. Bleiker MA, Sutherland I, Styblo K, Dam HG, Misljenovic O. Normas para la estimación del riesgo de infección tuberculosa según los resultados de la prueba tuberculínica en una muestra representativa de niños. Bol Union Int Tuberc Enf Resp 1989; 64:7-12.

  18. Sutherland I. Acerca del riesgo de infección. Bol Union Int Tuberc Enf Resp 1991; 66:209-211.

  19. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: Burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 6-24.

  20. Grzybowski S, Enarson DA. The fate of cases of pulmonary tuberculosis under various treatment programmes. Bull Int Union Tuberc Lung Dis 1978; 53:70-75.

  21. Smith I. The Stop TB Initiative. A partnership for action against tuberculosis. Tub Ind J 1999; 46(81):1-13.

  22. Cao JP, Zhang LY, Zhu JQ, Chin DP. Two year follow-up of directlyobserved intermittent regimens for smear positive pulmonary tuberculosis in China. Int J Tuberc Lung Dis 1998; 2:360.

  23. Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: Epidemiolgy and strategies for prevention. Tuberc Lung Dis 1992; 73:311-321.

  24. Angeles-Angeles A, Gassman N. Comparative demographic and autopsy findings in acquired immunodeficiency syndrome in two Mexican populations. J Acquir Immune Defic Syndr 1990; 3:579-583.

  25. Granich RM, Balandrano S, Santella AJ, Binkin NJ, Castro KG, Márquez- Fiol A et al. Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997. Arch Intern Med 2000; 160:639-644.




2020     |     www.medigraphic.com